Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| J07BK01 | VARIVAX | B | Varicella virus, live attenuated - 1350PFU | Injectable powder for suspension+diluent | 4102751.1525 | |
| J07BK01 | VARICELLA VACCINE LIVE | BioTech | Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated - | Injectable suspension | 3104276.175 | |
| J07BH01 | ROTATEQ ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT | B | Rotavirus G1, live attenuated - ≥2.2x106 IU, Rotavirus G2, live attenuated - ≥2.8x106 IU, Rotavirus G3, live attenuated - ≥2.2x106 IU, Rotavirus G4, live attenuated - ≥2.0x106 IU, Rotavirus P1, live attenuated - ≥2.3x106 IU | Suspension | 4508591.5875 | |
| J07BH01 | ROTARIX ORAL | B | Rota virus human RIX4414, live attenuated - ≥106 CCID50 | Suspension | 5167074.4125 | |
| J07BH01 | ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL FREEZE-DRIED) | BioTech | Rotavirus bovine-human , live attenuated - | Suspension | 2822069.25 | |
| J07BH01 | ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL LIQUID) | BioTech | Rotavirus bovine-human , live attenuated - | Liquid | 2822069.25 | |
| J07BG01 | RABIVAX-S (RABIES VACCINE INACTIVATED) | BioTech | Freeze dried inactivated purified rabies antigen (Pitman Moore PM3218 as virus strain) - | Injectable freeze dried material | 1552138.0875 | |
| J07BF03 | POLIOMYELITIS VACCINE INACTIVATED | B | Poliomyelitis virus type 1 inactivated - 40D.U, Poliomyelitis virus type 2 inactivated - 8D.U, Poliomyelitis virus type 3 inactivated - 32D.U | Injectable suspension | 1206770.565 | |
| J07BD52 | PRIORIX | B | Rubella virus live attenuated - ≥10³ CCID50, Mumps virus live attenuated - ≥103.7 CCID50, Measles virus live attenuated - ≥10³ CCID50 | Injectable lyophilised powder for solution+diluent | 1142266.125 | |
| J07BD52 | M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE) | B | Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated - | Injectable solution+diluent | 12924401.014875 | |
| J07BD52 | MEASLES, MUMPS AND RUBELLA VACCINE LIVE ATTENUATED (FREEZE-DRIED) MMR | G | Rubella virus live attenuated - ≥1000CCID50 /0.5ml, Mumps virus live attenuated - ≥5000CCID50 /0.5ml, Measles virus live attenuated - ≥1000CCID50 /0.5ml | Injectable freeze dried powder + diluent | 739113.375 | |
| J07BC02 | HAVRIX '1440' | B | Hepatitis A, inactivated, whole virus - 1,440 ELISA units/ml | 1,440 ELISA units/ml | Injectable suspension | 2215996.2825 |
| J07BC02 | HAVRIX JUNIOR 720 | B | Hepatitis A, inactivated, whole virus - 720 ELISA units/0.5ml | 720 ELISA units/0.5ml | Injectable suspension | 1491665.175 |
| J07BC02 | AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé) | B | Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml | 80 antigen units/0.5ml | Injectable suspension | 1531980.45 |
| J07BC02 | VAQTA | B | Hepatitis A, inactivated, whole virus - 25U/0.5ml | 25U/0.5ml | Injectable suspension | 2539862.325 |
| J07BC02 | HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED | BioTech | Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 0.5ml/dose | 0.5ml/dose | Injectable suspension | 1777903.6275 |
Download the new version of the MOPH app
for the latest updates on Coronavirus.
The new version of the MOPH APP will provide you with all the reliable information on COVID-19 with ongoing update of the confirmed cases and data. If you are showing any symptoms, the “Symptoms Checker” will be your self-help guide to assess them.
